Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
about
DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery.Meningiomas of the cerebellopontine angle: radiological differences in tumors with internal auditory canal involvement and their influence on surgical outcome.Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningiomaDevelopment of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1.The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trialPathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539.Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological gradePatterns of Care and Outcomes of Adjuvant Radiotherapy for Meningiomas: A Surveillance, Epidemiology, and End Results and Medicare Linked Analysis.Long Term Surgical Outcome and Prognostic Factors of Atypical and Malignant Meningiomas.Brain invasion in Meningiomas - Clinical considerations and impact of neuropathological evaluation: A systematic Review.Fluorescence-guided resection of extracranial soft tissue tumour infiltration in atypical meningioma.Microsurgical management of primary jugular foramen meningiomas: a series of 22 cases and review of the literature.World Health Organization grade II meningiomas.World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment.An analysis of prognostic factors associated with recurrence in the treatment of atypical meningiomas.The Role of Adjuvant Treatment in Patients with High-Grade MeningiomaThe anti-apoptotic protein survivin can improve the prognostication of meningioma patients.Radiotherapy versus observation following surgical resection of atypical meningioma (the ROAM trial).Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.Parameters influencing local control of meningiomas treated with radiosurgery.Amide proton transfer imaging for differentiation of benign and atypical meningiomas.Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control.New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing.WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment.Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system.Proton therapy for atypical meningiomas.A study of prognostic factors in 45 cases of atypical meningioma.Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas.
P2860
Q30359384-C26ACF45-2A79-4707-8638-81C46F84A7E0Q35303936-6F823393-E23D-4BCE-84BB-4156B1503D35Q35741539-47331280-F9E8-4B4B-B1E6-9A7371236151Q35848234-1B6D706A-B497-4D29-9FDF-55731143CB5DQ36293488-D9EB550A-E7E9-484F-93BB-5A017E3743C9Q36705923-F446A11E-C9A0-40A7-87CA-C642134A05B2Q36893234-A3A43283-0D8D-4940-9722-324A567EDE1BQ36900794-F1728A7F-64E9-4A7D-9432-9DC4D203C501Q37352522-2B324AD4-5FED-4FD9-A9CE-979B143E64DFQ38728877-388E9814-8240-42DB-AA95-50C0FCDB3979Q38843243-377FB215-0097-454C-8702-D54042BF253AQ38873834-4428E3C4-AE82-4685-BA2B-4942FC48876DQ39884623-A6BA8D47-9486-42B7-B992-C27C477E99E5Q40812108-79685C00-B17C-4533-88A8-C79F7FFC6EFDQ40990375-D40232BB-8E26-41CD-A518-94E4FB37DC61Q41271334-1354335B-E17F-4B4A-B211-C25B1CFED89CQ41973584-4A62E9CF-44E0-4276-8C07-00AFA18259A7Q42949180-876E9F52-0322-4A97-BF20-3A7A3573EF74Q46115389-9A37A0C3-2D37-483F-96EA-1CE79A9CF584Q46791478-D8D28AED-5CEA-4B4A-963F-0A3DBD93305CQ48036634-6C7C104C-3D9F-48EB-B502-1A3F98098D5DQ48108604-64F606CA-C510-4691-ACC0-7A791751E66DQ50058120-C05C26D0-5A6C-4D36-AF50-E96D358E5DC6Q52646651-8B1FC5B8-F5F2-4BA9-8AEB-C48EE1946AFEQ52863797-436BC598-E116-415D-8956-3E50240C3E15Q53117505-28C845CB-F8EA-435B-B849-39CB16DD4B49Q53548356-943C4EA8-56BD-46C2-9DF2-027A73F0AAC7Q53755702-4D5619F4-8BF6-4297-AFC0-6576462F5761Q55313347-DD535282-B8DD-47F7-A38E-447E64FDB88CQ55416904-209F716B-39A2-4526-9746-2539956331A9
P2860
Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
@en
type
label
Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
@en
prefLabel
Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
@en
P2093
P2860
P356
P1433
P1476
Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
@en
P2093
Andrew T Parsa
C David James
Eli T Sayegh
Gurvinder Kaur
Igor J Barani
Matthew Z Sun
Michelle Madden
Orin Bloch
P2860
P304
P356
10.1093/NEUONC/NOU025
P577
2014-04-02T00:00:00Z